Newborn Screening Market Size Worth USD 2.27 Billion By 2027

The Global Newborn Screening Market is forecasted to reach USD 2.27 Billion by 2027, according to a new report by Emergen Research. Newborn screening tests in infants check for developmental, metabolic, and genetic abnormalities.

Newborn screening includes more than 30 illnesses and conditions. Additionally, various governmental and non-profit agencies are primarily focusing on providing quality fetal and maternal care. Besides, the industry is expected to experience a boost in demand due to the involvement of federal bodies involved in coordinating awareness and quality control programs to imbibe confidence and low the number of deaths caused by negligence and non-screening.

Read More: https://www.emergenresearch.com/industry-report/new-born-screening-market

New treatments such as enzyme replacement therapy, hematopoietic stem cell transplant, gene therapy, and novel therapeutic drugs have allowed the inclusion of autoimmune disorders as possible candidates in NBS programs.